MedTrace Logo

Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions

NCT07213154 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2025-12-16

No results posted yet for this study

Summary

This clinical trial studies how well an optical imaging scan called quantitative oblique back-illumination microscopy (qOBM) helps in diagnosing skin cancer in patients with skin lesions. qOBM is a non-invasive procedure that uses red light for illumination, and may work better than no imaging procedures in aiding doctors in diagnosing skin lesions.

Conditions

  • Malignant Skin Neoplasm
  • Skin Disorder
  • Skin Neoplasm

Interventions

PROCEDURE

Quantitative Oblique Back-Illumination Microscopy

Undergo qOBM

RADIATION

Radiation Therapy

Undergo SOC RT

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Emory University

    lead OTHER

Principal Investigators

  • Mohammad K. Khan, MD, PhD, MS, FACRO, FACR, DABR · Emory University Hospital/Winship Cancer Institute

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-15
Primary Completion
2026-09-17
Completion
2027-09-17
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07213154 on ClinicalTrials.gov